期刊
GENE THERAPY
卷 12, 期 2, 页码 187-193出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.gt.3302404
关键词
tissue-specific promoters; transductional targeting; transcriptional targeting; dual targeting; adenovirus
类别
资金
- NCI NIH HHS [R01 CA090547, P50 CA89019] Funding Source: Medline
- NHLBI NIH HHS [R01 HL67962] Funding Source: Medline
- NIA NIH HHS [R01 AG021875] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA090547, P50CA089019] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067962] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R01AG021875] Funding Source: NIH RePORTER
Adenoviruses ( Ads) are efficient gene transfer vehicles, but Ad-mediated gene therapy for ovarian cancer remains limited in vivo by inefficient and nonspecific gene transfer. Mesothelin (MSLN), a cell surface glycoprotein, is overexpressed in ovarian cancer but not in normal tissues except mesothelial cells. Therefore, MSLN is an attractive candidate for transcriptional and transductional targeting in the context of ovarian cancer gene therapy. We evaluated the expression of MSLN mRNA and MSLN surface protein in ovarian cancer cells. Ads containing the MSLN promoter driving reporter gene expression were created and tested in ovarian cancer cell lines and purified ovarian cancer cells isolated from patients. To evaluate transductional targeting, we used an Ad vector containing an Fc-binding domain within the fiber protein, which served as a docking domain for binding with anti-MSLN immunoglobulins. Both RT-PCR and flow cytometry revealed high MSLN gene and protein expression in ovarian cancer cells. The MSLN promoter was activated in ovarian cancer cells, but showed significantly reduced activity in normal control cells. Transductional targeting of Ads via anti-MSLN antibody increased transgene expression in ovarian cancer cells. This report describes the use of MSLN for transcriptional as well as transductional targeting strategies for ovarian cancer gene therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据